Livionex Selected as a 2016 Red Herring Top 100 North America Winner

Share Article

Silicon Valley Specialty Pharmaceutical Company Recognized for Breakthrough Technology in Treating World’s Most Prevalent Chronic Diseases~

Livionex, Inc. announced today its selection as a winner of the Red Herring Top 100 North America award, which recognizes leading private companies from the region and celebrates these startups’ innovations and technologies across their respective industries.

Silicon Valley-based Livionex was selected for this award for its disruptive technology in treating periodontitis, cataracts and arthritis. Livionex technology addresses the metal mediated pathway for diseases and is based on over a decade of collaborative research with top US universities. The company’s first product to market, Livionex Dental Gel, breaks the bond between plaque and your teeth at the molecular level.

In multiple published studies, including one from the University of California, Irvine, Livionex cleaned teeth two and a half times more effectively than traditional toothpaste. “The Livionex dental gel reinvents the toothpaste paradigm and provides results traditional toothpastes simply cannot achieve,” notes Livionex Founder and CEO Amit Goswamy.

Red Herring Top 100 America enlists outstanding entrepreneurs and promising companies. It selects the award winners from approximately 1,200 privately financed companies each year in the US and Canada. Since 1996, Red Herring has kept tabs on these up-and-comers. Red Herring editors were among the first to recognize that companies such as Facebook, Twitter, Google, Yahoo, Skype,, YouTube, Palo Alto Networks and eBay would change the way we live and work.

“In 2016, selecting the top achievers was extremely difficult,” said Alex Vieux, publisher and CEO of Red Herring. “The variety, depth, disruption and traction we saw from the early stage companies to those with significant scale made it one of the toughest vintages to judge. The North America winners are representative of the amazing ecosystem that never ceases to astound, with new and experienced entrepreneurs continuing to push the barriers of innovation. As one of the winners, Livionex should be proud of its accomplishment under such strong competition.”

Red Herring’s editorial staff evaluated companies on both quantitative and qualitative criteria, such as financial performance, technological innovation and intellectual property, DNA of the founders, business model, customer footprint and market penetration. This assessment of potential is complemented by a review of the track record and standing of startups relative to their sector peers, allowing Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in North America.

About Livionex
Livionex Inc. was founded in 2009 by Stanford and Berkeley alums with the goal of enhancing the quality and longevity of human life. The company is focused on addressing the role of metal ions in aging and diseases of the human body. The technology is the result of over 10 years of extensive research by key members of the Livionex team in close collaboration with scientists at world renowned research institutions including the University of Texas and the University of California. Livionex is a recipient of prestigious research grants from the US National Institutes of Health (NIH) and the US Department of Defense (DOD). In addition to Livionex Dental Gel, the company is leveraging its technology platform to develop products targeting large unmet medical needs in oral care, ophthalmology and dermatology. The gel is currently available on-line at, select health food stores, and dental offices.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Melanie Frenkel
Signature Green
+1 (602) 476-2547
Email >